Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

University of Florida, Gainesville, and a lead investigator in this Phase IIb study.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and a leading cause of cirrhosis, liver cancer and the need for liver transplants. According to the Centers for Disease Control and Prevention (CDC), an estimated 4.1 million Americans (1.6 percent) have been infected with hepatitis C; 3.2 million are chronically infected. The number of new infections per year has declined from an average of 240,000 in the 1980s to about 26,000 in 2004. CDC estimates the number of hepatitis C-related deaths could increase to 38,000 annually by the year 2010, surpassing annual HIV/AIDS deaths.

About PEGASYS

PEGASYS, in combination with COPEGUS (ribavirin), are indicated for the treatment of adults with chronic hepatitis C who have compensated liver disease and have not previously been treated with interferon alpha. Efficacy has been demonstrated in patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are clinically stable (e.g., antiretroviral therapy not required or receiving stable antiretroviral therapy). In addition, PEGASYS in combination with COPEGUS is the first and only FDA-approved regimen for the treatment of chronic hepatitis C in patients coinfected with hepatitis C and HIV. PEGASYS is the only pegylated interferon indicated for the treatment of adult patients with chronic hepatitis B (HBeAg positive and HBeAg negative chronic hepatitis B who have compensated liver disease and evidence of viral replication and liver inflammation).

PEGASYS is dosed at 180mcg as a subcutaneous injection taken once a week. COPEGUS is available as a 200mg tablet, and is administered orally two times a day as a split dose. Roche has backed PEGASYS with the most extensive clinical research program ever undertaken in hepatitis C, with major studies initiated to advance treat
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015 Research and Markets ... of the "Urological Catheters - Global ... offering. This report analyzes the ... Units and US$ Thousands by the following ... Peritoneal Catheters), and Urinary Catheters (Foley Catheters, ...
(Date:3/30/2015)... WILMINGTON, Del. , March 30, 2015  Rigrodsky & ... Auspex Pharmaceuticals, Inc. (NASDAQ GM: ASPX )? , ... 30, 2015? , Do you think the proposed buyout ... discuss your rights? Rigrodsky & Long, ... against the board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" ...
(Date:3/30/2015)... -- Caris Life Sciences® today announced the presentation of a ... potentially significant benefit in a select subset of patients ... in an oral presentation in a Plenary Session at ... on Women,s Cancer in Chicago, Ill. ... presented at the annual meeting that utilizes Caris Molecular ...
Breaking Medicine Technology:Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4
... 2011 Mylan Inc. (Nasdaq: MYL ) today ... (GPhA) as further evidence of the savings and access that ... American consumers. According to the independent analysis ... of market intelligence to the pharmaceutical and health care industries, ...
... global cardiovascular device industry is expanding quickly, with industry ... 2015. The boom in demand for ... growing number of heart health-related diseases: the American Heart ... world currently suffer from cardiovascular diseases. More ...
Cached Medicine Technology:Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs 2Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs 3Cardiovascular Device Market Research Update- September 2011 2
(Date:3/30/2015)... 30, 2015 Health Fitness Revolution, founded by ... the World Samir Becic, has created a new list of ... which recognizes the world’s fittest leaders in terms of physical ... only list of its kind to detail the health and ... Among the world leaders profiled on the list are Israel’s ...
(Date:3/30/2015)... 30, 2015 In its 2015 survey ... Robins & Morton sixth among the top general contractors ... Morton has specialized in healthcare construction for more than ... & Morton ranked on the list with $657 million ... company built 2.6 million square feet with 82 percent ...
(Date:3/30/2015)... 30, 2015 The fertility team at ... most frequently asked questions to give intended parents across ... egg donation. , After unveiling the most ... February, the IVF clinic has witnessed an increase in ... fertility center provides attentive reproductive care — with all-inclusive ...
(Date:3/30/2015)... Innovaacom, a leading provider of medical education ... is expanding its services into Asia in 2015. Innovaacom’s ... world comes at a time when Asia’s strengthening economy ... healthcare. A rapidly growing aging population and changing socio-economic ... medicine in Asia. “We are excited to be a ...
(Date:3/30/2015)... UT (PRWEB) March 30, 2015 On March ... Business Owners Day. In honor of all small business owners, ... will be spotlighting them. , According to Zane Benefits' ... of our economy, creating 75% of all jobs and employing ... America account for 54% of all U.S. sales. The small ...
Breaking Medicine News(10 mins):Health News:The Top 13 Fittest Heads of State: Why Putin Might Be No. 1 in Health and Fitness 2Health News:Modern Healthcare Ranks Robins & Morton No. 6 Contractor 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2
... is one of the greatest challenges facing researchers today, and ... contain a growing epidemic.// The World Health Organization has estimated ... overweight problems, of them nearly 300 million are obese. ... that works on the source of the problem – appetite, ...
... the US have won this year's Nobel Prize for ... by double-stranded RNA, it was announced here Monday. ... in awarding them the 10-million-kronor ($1.37-million) prize. ... controlling the flow of genetic information", the institute said. ...
... recent study has revealed that children in deep sleep awoke ... name and ordering them out of their bedrooms –although they ... ,Dr. Gary Smith, one of the co-authors of the ... that what works for adults doesn't always work for children.,"Clearly, ...
... The deadly dengue viral enveloped 40 more people in the ... but the authorities// stated that the situation did not warrant ... to curb this menace. Our hospitals are well equipped to ... declare dengue as epidemic," said Health Minister Yoganand Shastri. ...
... to 100,000 people affected by chikungunya, a viral fever caused ... for confusing the state government on the nature of the ... it is not chikungunya. The government is doing its best ... and we have asked people from other systems of medicines ...
... Doctors operated upon a young man and took out at ... hospital in Tamil Nadu, which he had swallowed six months ... surprised that he lived for six months with the pin ... had swallowed apparently gone down his throat effortlessly and the ...
Cached Medicine News:Health News:Brain behind the Brawn: Vital Molecule in the Brain Controls Appetite 2Health News:Two Americans Share 2006 Nobel Medicine Prize 2Health News:Mummy’s Voice More Effective than Smoke Alarm 2Health News:Dengue Outbreak in the Capital is not an Epidemic: Government 2
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Intended for the quantitative determination of direct bilirubin in serum. Modified EvelynMalloy Method. Endpoint Reaction. Wavelength: 555 nm. Linearity: 20 mg/dl (340 mol/l)...
... microplate spectrophotometer designed specifically to run 24 ... With rugged hardware, proven optical performance and ... of traditional spectrophotometry to obtain results quickly, ... read up to eight, 1 cm Biocell ...
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
Medicine Products: